Other substances

Cilostazol

A quinolinone phosphodiesterase III inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
2
 AI-suggested references
0
 Clinical trials

General information

Cilostazol on PubChem

Marketed as

CILOSTAZOL; PLETAAL

 

Structure image - Cilostazol

C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4

Supporting references

Link Tested on Impact factor Notes Publication date
Superiority of cilostazol among antiplatelet FDA‐approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach
Spike protein 3CLpro Small molecule In silico Screening 		in silico 1.90

Predicted to inhibit the SARS-CoV-2 3C-like protease and spike protein.

 Sep/27/2020

AI-suggested references

Link Publication date
Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
Sep/12/2021
Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach
Jan/22/2021
Export (.csv)